Weatherford (NASDAQ: WFRD) to buy NCS Multistage (NCSM) for 0.463 Weatherford shares
Rhea-AI Filing Summary
NCS Multistage Holdings, Inc. agreed to be acquired by Weatherford International plc under a definitive agreement. Stockholders may elect either Weatherford common stock or a stock-plus-cash option; on a blended basis the consideration equals 0.463 shares of Weatherford common stock per NCS Multistage share, with up to 19.99% of total equity consideration payable in cash. The transaction was approved by both boards and NCS Multistage’s controlling stockholder, is subject to customary closing conditions and regulatory approvals, and is expected to close in the second half of 2026. The companies expect at least $15 million of annual run-rate cost synergies realized within 18 months of closing and state the deal is expected to be immediately accretive to adjusted Free Cash Flow per share.
Positive
- None.
Negative
- None.
Insights
Blended stock consideration of 0.463 shares and $15M synergies noted; timing and approvals remain key.
The agreement offers NCS Multistage holders a choice of stock or a stock-plus-cash mix, with a stated blended exchange ratio of 0.463 Weatherford shares per NCS Multistage share and up to 19.99% payable in cash. The companies disclose estimated annual cost synergies of $15 million, expected to be realized within 18 months of closing.
Completion depends on customary closing conditions and regulatory approvals, and the transaction is expected to close in the second half of 2026. Subsequent filings (Form S-4, Schedule 14C) will provide detailed terms, proration mechanics, and any adjustments.
Weatherford states the deal will be immediately accretive to adjusted Free Cash Flow per share; detailed financials pending.
The announcement declares immediate accretion to adjusted Free Cash Flow per share and quantifies at least $15 million in annual run-rate cost synergies. The exchange options are described as either 0.554 Weatherford shares or 0.239 shares plus a cash amount equal to 0.137 shares, subject to proration and adjustments.
Investors should review the forthcoming Form S-4 for pro forma metrics, dilution effects, and the proration methodology that determines the final mix of stock and cash consideration.